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Background: Discordant findings between aortic valve area (AVA<1.0cm2) and mean gradient (MG<40mmHg) may raise uncertainty about the 
actual severity of the stenosis. Some investigators suggested that this discordance is consistent with moderate AS. Accordingly, they proposed to 
lower the AVA cut-off value for severe AS down to 0.8cm2. However other investigators reported that this clinical presentation often reflects the 
presence of a severe AS with concomitant “paradoxical” low flow (PLF) (i.e. reduced stroke volume index (SVi) despite preserved LVEF). The main 
objective of this study was to analyze the impact of aortic valve replacement (AVR) on survival in patients with AVA comprised between 0.8 and 1 
cm2.
Method and Results: Among 729 consecutive patients with severe AS (AVA<1.0 cm2) and preserved LVEF (>50%), 369 (51%) had an AVA 
comprised between 0.8 and 1 cm2. These patients were separated into 4 groups according to the levels of LV outflow (normal flow (NF): SVi>35ml/
m2 vs. PLF: SVi≤35) and MG (low MG (LG) <40mmHg vs. high MG (HG)≥40).The 369 patients were distributed in NFHG: 92 patients (24.9%), NFLG: 
167 (45.3%), PLFHG: 2 (0.5%) and PLFLG: 108 (29.3%). We compared the effect of AVR on survival in the whole cohort and in LG groups, i.e. the 
groups where there is an uncertainty about stenosis severity. To eliminate covariate differences, a propensity score adjustment was used. 5-year 
overall survival was lower in the PLFLG (64 ±5%) and NFLG (73 ±4%) groups compared to the NFHG (89 ±4%) groups (p=0.001). In multivariable 
analysis, AVR (tested as a time dependent covariate) was associated with markedly reduced mortality in the whole cohort (n=369) (HR=0.50; 95% 
Confidence Interval [95%CI]=0.28-0.92; p=0.02) and in the subset of patients with PLFLG (HR=0.30; 95% 95%CI=0.10-0.94; p=0.04), but not in 
the NFLG group (p=0.26).
Conclusion: Among patients with AVA comprise between 0.8 and 1.0 cm2 AVR is independently associated with a significant protective effect 
in patients with PLFLG but not in those with NFLG. This may be due to the fact that this NFLG pattern reflects a less severe stenosis and/or 
measurement errors. Nevertheless, these findings support statu quo for the current AVA cut-off value (1.0 cm2).
